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Abstract
Background: Cervical cancer is the third most common cancer in women after breast
and colorectal cancers, and one of the leading causes of cancer death among women
worldwide. The aim of this study is to determine the associations of cervical cancer
incidence and mortality rates with the Human Development Index. 
Methods: Information of the incidence and mortality rates for cervical cancer were
obtained from the GLOBOCAN Cancer Project for 2012 and data for the Human
Development Index for 2013 from the World Bank database. We used linear regression
models to assess the Human Development Index effect on cervical cancer occurrence rates.
Inequality in the age-standardized incidence and mortality rates of cervical cancer
according to the Human Development Index were assessed by the concentration index.
Results: The results showed substantially higher cervical cancer incidence and
mortality rates in regions with low and medium Human Development Index compared
to regions that had substantially elevated Human Development Index. The death and
incidence from cervical cancer were more concentrated in low Human Development
Index countries. There was a significant negative association between the cervical cancer
incidence and mortality rates with all the components of the Human Development Index,
including life expectancy (B= -0.98, P<0.001), mean years of schooling (B= -1.86,
P<0.001), gross national income (B= -0.38, P<0.001), urbanization level (B= -0.29,
P<0.001), and age standardized obesity (B= -0.45, P<0.001). 
Conclusion: Cervical cancer is a significant public health problem in countries
with low Human Development Index and requires the implementation of prevention
programs and screening for early detection and treatment.  
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Cancer Project
Received: July 16, 2017; Accepted: December 03, 2017
Kamyar Mansori et al.
Middle East J Cancer 2018; 9(3): 235-242236
Introduction 
Cancer is a major public health concern and the
second leading cause of death behind
cardiovascular diseases with over 8 million deaths
worldwide in 2013.1-3 Despite substantial progress
in cancer prevention and treatment in recent years,
the cancer burden and risk factors have increased
worldwide.4-6 Cervical cancer (CC) ranks third
among the most common cancers of women after
breast and colorectal cancers, and one of the main
causes of cancer deaths throughout the world.7 In
2008, approximately 530,000 women were
diagnosed with CC worldwide and 257,000
women died from this cancer.8 Cervical cancer has
a higher incidence of mortality in most East
African and South Asian countries compared to the
rest of the world.7,8 There is a vast variation in the
incidence and mortality of CC in different regions
of the world, such that 86% of all CC cancer
cases and 88% of all CC deaths occur in
developing countries.7-9 In Iran, CC is the third
leading cause of death with 50000 new cases
each year.10 The latest report from the Cancer
Registry in Iran indicated CC incidence rate of
2.61 per 100,000 individuals.11 According to the
latest data from the World Health Organization,
significant disparities exist in the incidence and
mortality of CC worldwide.7,8
Some studies from developed countries have
reported an association between socioeconomic
gradients and CC incidence and mortality. In
groups with lower socioeconomic status, the risk
of CC was 2-3 times more compared to their
affluent counterparts.12,13 Assessment of the effects
of socioeconomic status and Human Development
Index (HDI) are significant because they represent
underlying causes of health inequalities both
within and between nations.14,15 Examination of
global inequalities is important in that CC tends
to have greater impact on younger women (aged
<45 years) compared to other major cancers,
which contribute to higher years-of-life lost,
especially among women in the developing world. 
Various studies have examined the association
of cancers with HDI,16-19 however there appear to
be few studies, particularly in developing
countries, that have examined disparities in CC
incidence and mortality rates between countries
due to social inequality and human development
factors. Therefore, the purpose of this study was
Figure 1. World map shows Human Development Index (HDI) categories by country (based on 2013 data).
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to quantify the links between specific components
of HDI [life expectancy at birth, education, gross
national income (GNI) per 1000 capita, health, and
living standards] with burden indicators of CC. We
obtained data from the International Agency for
Research on Cancer (IARC), which represented
the most up-to-date information on the incidence
of CC worldwide.7
Materials and Methods
We performed this ecological study on a dataset
regarding the incidence and mortality rates of
CC and some related health factors worldwide.
Data that pertained to the incidence and mortality
rates of cancers were obtained from the Global
Cancer Project for 172 countries in 2012.20 We
obtained data about the HDI 2013 and its gradient
that included the following: life expectancy at
birth, mean years of schooling, GNI per capita, and
other health-related variables from the World
Bank database for 169 countries.21
Data analysis was restricted to 169 countries
which had both the epidemiologic data from the
GLOBOCAN database and HDI. These countries
were placed into four categories: (1) very high
human development (27 countries), (2) high
human development (37 countries), (3) medium
human development (89 countries), and (4) low
human development (16 countries). We defined
inequality in the age-standardized incidence and
mortality rates (ASR) of CC according to the
HDI by using the concentration index. The value
of the concentration index ranged from -1 to +1
where the negative value indicated that the health
variable was more concentrated in the poor
population. A positive value indicated the rich
population. One-way ANOVA was used to
compare means of CC incidence and mortality in
different HDI group countries. We also used linear
Figure 2. Worldwide age-standardized incidence rates (ASR) per 100,000 for cervical cancer (CC) in 2012.
Table 1. Concentration indexes for inequality of incidence and mortality of cervical cancer (CC) according to the Human Development
Index (HDI).
Cancer type New cases diagnosed Death from CC Incidence concentration Mortality concentration 
in 2012 (1,000s) in 2012 (1,000s) index (95% CI) index (95% CI)
Cervical 528 266 -0.2 (-0.25, -0.15) -0.3 (-0.38, -0.25)
Kamyar Mansori et al.
Middle East J Cancer 2018; 9(3): 235-242238
regression models to assess the HDI effect and
other variables on SC occurrence rates. A P-value
less than 0.05 was considered significant. All
statistical analyses were performed with Stata
software version 12 (StataCorp., College Station,
TX, USA).
Results
The study analyses constituted a global
overview of the current patterns of cancer
incidence and mortality in relation to predefined
levels of HDI. Figure 1 shows the HDI categories
by country based on 2013 data. Figure 2 shows the
worldwide distribution of incidence of ASR for CC
per 100,000 in 2012. 
The concentration index and 95% confidence
interval for incidences, mortality, and
incidence/mortality rates for CC are presented in
table 1. The negative value for the concentration
index in table 1 and results from figure 2 for
death and incidence from CC indicated that this
cancer was more concentrated in low HDI
countries.
Table 2 shows the incidence and mortality
rates of CC in various regions according to HDI.
The incidence and mortality rates for CC were
substantially higher in regions with low and
medium HDI compared to regions that had
substantially high and high HDI. 
Table 3 shows the associations of CC incidence
and mortality rates with HDI components. Results
of the linear regression model in this table show
a significant negative association of CC incidence
and mortality rates with all components of HDI -
including life expectancy (B= -0.98, P<0.001),
mean years of schooling (B= -1.86, P<0.001),
GNI (B= -0.38, P<0.001), urbanization level (B=
-0.29, P<0.001), and age standardized obesity
(B= -0.45, P<0.001). 
Discussion 
This study aimed to perform a global survey of
the current patterns of cancer incidence and
mortality in relation to predefined levels of HDI.
We used the HDI as an indicator of socioeconomic
development and incidence and mortality rates for
CC as indicators of the extent of the cancer
transition globally. The results of this study
showed that the incidence of CC and mortality
rates varied widely. The incidence and mortality
of CC in various regions differed according to HDI
in these regions. Incidence and mortality rates of
CC were substantially higher in regions with low
and medium human development compared to
regions that had substantially high and high human
development. The high rates of incidence and
mortality for many low- and middle-income
countries showed CC to be a significant public
health problem in developing countries.  
Our study showed that the highest ASR for CC
were related to countries that had medium and low
human development. These results were consistent
with similar studies performed in this field.22-25
Possibly, in countries with medium and low human
development, the frequency of important risk
factors that include early age at first sexual
intercourse, early age at first delivery, high number
of pregnancies, smoking, failure to be screened and
treated for precancerous lesions, long-term use of
hormonal contraceptives, numerous sexual
partners, high-risk partners, infection with human
immunodeficiency virus (HIV) or other sexually
transmitted infections (STI) such as herpes virus
or Chlamydia trachomatis, immunosuppression
Table 2. Cervical cancer (CC) incidence and mortality in different Human Development Index (HDI) regions in 2012.
Index Region P-value
(F-test)
Substantially high High human Medium human Low human
human development development development development
CC incidence CR 9.8±1 12.75±1.36 19.28±1.08 20.46±2 <0.001
ASR 7.7±0.85 10.18±1 21.08±1.3 33.07±3.1 <0.001
CC mortality CR 3.5±0.23 5.2±0.59 8.7±0.51 13.2±1.3< 0.001
ASR 2±0.2 3.36±0.36 10.13±0.76 22.6±2.1 <0.001
CR: Crude rate; ASR: Age-standardized rates per 100,000
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due to HIV, other diseases, chemotherapy, or
other causes associated with CC are more common
compared to countries with substantially high
and high human development.22,24 Drain et al.
reported that countries with high incidence rates
tended to have more total fertility, lower ages at
ﬁrst childbirth, and a higher percentage of males
with non-regular sex partners. Countries with
high CC rates tended to have younger, less
educated, and more illiterate populations.24 On the
other hand, one of the most important factors for
CC is human papilloma virus (HPV) infection. The
virus is transmitted through sexual contact and has
high incidence and prevalence due to the lack of
sexual health in countries with low human
development. The Pap smear screening test is
used to identify HPV.26,27 In developed countries
with high human development, the incidence and
mortality rates of CC have significantly decreased
through regular Pap smear screening and early
detection.28,29 In developing countries with low
HDI, despite the increased frequency of the virus
due to poor sexual health, there are no regular
screening programs and a large number of these
countries screen for CC with very poor quality
screening tests, low coverage rates, and little
ﬁnancial support.30 As a result, these countries
have CC incidence and mortality rates more than
those of developed countries that have national CC
prevention programs.7,27
In the current study, results of the linear
regression model showed a significant association
of CC incidence and mortality rates with HDI
components that included life expectancy,
education, GNI, urbanization level, and age
standardized obesity. 
Life expectancy at birth was one of the
components of HDI that had a negative association
with CC incidence and mortality rates. This result
was consistent with similar studies that conducted
in this field.23,24 It might be because the majority
of risk factors of this cancer have been attributed
to many sexual and reproductive behaviors.
Exposure to these important risk factors occurs
before aging. One of the most important risk
factors for CC is infection with HPV where the
person becomes infected during sexual activity. On
the other hand, there is little sexual activity in the
elderly. As a result, the high incidence and
mortality rates of CC occur in earlier ages.24,31   
Education and years of schooling is another
component of HDI that can affect incidence and
mortality rates of CC. In the current study, we have
shown that this dimension had a negative
association with these rates where, with higher
educational levels, the incidence and mortality
of CC were lower. Perhaps this was due to the fact
that women with low educational levels had less
information about risk factors of this cancer and
its prevention. Less educated women were more
likely to face numerous factors such as insufficient
access to medical care, lack of culturally
competent care, and lack of effective health
education about STI prevention and Pap
screening.24,32 Therefore, these factors would
cause the woman not to pay attention to risk
factors and screening at the proper time. Therefore,
she would be diagnosed at an advanced stage
where the risk of death was higher. 
One of the components of the HDI is adequate
Table 3. Effect of the Human Development Index (HDI) components and demographic variables on cervical cancer (CC) incidence and
mortality rate.
Variable CC incidence CC mortality
B 95% CI P-value B CI P-value
Life expectancy at birth -0.98 (-1.16, -0.8) <0.001 -0.79 (-0.9, -0.68) <0.001
Mean years of schooling -1.86 (-2.5, -1.22) <0.001 -1.77 (-2.17, -1.38) <0.001
Gross national income (GNI) -0.38 (-0.49, -0.3) <0.001 -0.28 (-0.35, -0.2) <0.001
per 1000 capita
HDI -51.33 (-62.6, -40) <0.001 -43.7 (-50.3,-37) <0.001
Urbanization level (%) -0.29 (-0.38, -0.2) <0.001 -0.24 (-0.29, -0.18) <0.001
Age standardized obesity in adults -0.45 (-0.64,-0.25) <0.001 -0.41 (-0.54, -0.29) <0.001
B: Beta coefficient that reflects the strength of association between incidence and mortality rate of CC and HDI 
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income, as specified by GNI per 1000 capita.
This factor in the study had a negative association
with CC incidence and mortality. This finding
was consistent with the results of similar
studies.23,24 In developed countries with higher
socio-economic levels and income, people have
more appropriate and easier access to diagnostic
services and screening tests compared to
developing countries with lower income levels. As
a result, cancer would be diagnosed at the local
stage with a lower risk for mortality.  
Another component of HDI is the urbanization
level that had a negative association with incidence
and mortality of CC. This inverse relationship
might be partly due to differences in
socioeconomic deprivation in urban and rural
areas.33 Poverty, unemployment, low educational
level, and low income are higher in rural areas
compared to urban areas. People in these regions
have little information about risk factors and
screening programs, and insufficient access to
diagnostic and screening services. As a result,
people who live in rural areas have “higher”
incidences and mortality rates of CC.17,33
The final component of HDI is age
standardized obesity in adults. This dimension
had also a negative association with the incidence
and mortality of CC. This result was not consistent
with other studies in this field. Excessive fat leads
to increased estrogen levels, and subsequent
development of endometrial and CC. Thus,
overweight women are at high risk for morbidity
and from CC.34-37 In this study, the inverse
relationship between CC and obesity may have
been the result of a lack of control of confounders.
Possibly the reason is that obese women who
reside in urban areas have higher educational
levels and socio-economic status with better access
to diagnostic and screening services. Thus, an
inverse relationship between obesity with
incidence and mortality rates of CC should be
interpreted with caution.  
In conclusion, CC incidence and mortality
rates varied widely according to HDI. The
incidence and mortality rates of CC were
substantially higher in regions with low HDI
compared to high HDI. On the other hand, HDI
was a strong predictor for CC incidence and
mortality rates. All components of HDI had a
negative association and significance with
incidence and mortality of CC. It seemed that
CC was a significant public health problem in
countries with low HDI and would require
implementation of prevention programs and
screening for early detection and treatment.  
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